Hypomethylation status of miR-657 promoter region as biomarker for diagnosis of hepatocellular carcinoma: a retrospective study.

Shi, Zhaoqi; Luo, Peng; Fan, Xiaoxiao; Pan, Junhai; He, Lifeng; Zhou, Daizhan; Lin, Hui

Shi, Zhaoqi; Luo, Peng; Fan, Xiaoxiao; Pan, Junhai; He, Lifeng; Zhou, Daizhan; Lin, Hui.

Afiliación

Shi Z; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Luo P; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Fan X; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Pan J; State Key Laboratory of Modern Optical Instrumentations, Centre for Optical and Electromagnetic Research, College of Optical Science and Engineering, International Research Center for Advanced Photonics, Zhejiang University, Hangzhou, China.
He L; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Zhou D; Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Lin H; Eye Center of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Transl Cancer Res ; 11(5): 1112-1121, 2022 May.

Article en En | MEDLINE | ID: mdl-35706811

Palabras clave

Hepatocellular carcinoma (HCC); biomarker; methylation; miR-657

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Transl Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google